Press Release

CSRxP: Court Ruling Underscores Need For Congressional Action To Boost Prescription Drug Transparency

Jun 17, 2020

Lawmakers Must Step-in to Enact DTC List Price Disclosures, Additional Read More

CSRxP Launches “No Price Hikes” Campaign Urging Big Pharma To Suspend Summer Price Hikes

Jun 2, 2020

Drug Companies Must Forgo Mid-Year Price Increases While Millions of Americans Read More

CSRXP: PUBLIC-PRIVATE PARTNERSHIP WILL HELP DELIVER RELIEF FROM BIG PHARMA’S INSULIN PRICE-GOUGING

May 27, 2020

Coalition Applauds Positive Step from the Administration to Lower Insulin Read More

CSRxP: New Study Undercuts Bogus Net Price Refrain From Big Pharma

Mar 4, 2020

Brand Name Drug Companies Repeated List Price Hikes Lead to Higher Net Prices Read More

CSRxP LAUNCHES SEVEN-FIGURE “PROMISE” CAMPAIGN URGING CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Feb 4, 2020

Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Read More

CSRxP: SOTU 2020 OFFERS PRESIDENT UNIQUE MOMENT TO LEAD ON LOWERING Rx PRICES

Feb 3, 2020

Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Read More

CSRXP APPLAUDS SENATE PASSAGE OF USMCA THAT PUTS AMERICAN PATIENTS FIRST

Jan 16, 2020

Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision Read More

CSRXP: BIG PHARMA THUMBS ITS NOSE AT STRUGGLING AMERICANS WITH NEW YEAR PRICE HIKES

Jan 2, 2020

Drug Makers, Including Brand Name Giants Like Pfizer, Increase Prices on More Read More

CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB

Dec 12, 2019

Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress Read More

CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D

Dec 10, 2019

Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times Read More

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

Nov 22, 2019

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers Read More

CSRxP: Policymakers Must Remove Big Pharma Carveout in USMCA

Oct 23, 2019

Washington Can Put Patients First By Amending Trade Provision That Would Read More